All filters
Abstracts
Effectiveness and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in HIV-1-infected adult patients in German routine clinical practice – 12-month results of the BICSTaR cohort
C. StephanÂ
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Â
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Long-Acting Cabotegravir + Rilpivirine for HIV Treatment: FLAIR Week 96 Results
R. D'Amico
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Optimisation of First-Line Antiretroviral Therapy (ART) for Children Living with HIV in Uganda: Translation from policy to action
E. Magongo
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Â
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Dual therapy including dolutegravir plus boosted-darunavir ensures high rate of virological control and rare resistance selection at failure in heavily treatment experienced PLWH
D. Armenia
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Dual therapy with Dolutegravir plus Lamivudine in virologically suppressed patients
C. Valente
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Real-world effectiveness of elbasvir/grazoprevir in the treatment of patients with hepatitis C virus genotype 1a infection in Norway
R. Leiva
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
HIV A1 or B Do Not Differentially Impact Cabotegravir In Vitro Potency or Durability
J. Jeffrey
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
HIV evolution in patients initiating antiretroviral therapy during primary infection
B. Abdi
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Molecular Epidemiology of the HIV-1 Infection in Cyprus (2017-2019): A Polyphyletic Infection with an Increasing Prevalence of Drug Resistance
L. Kostrikis
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
A changing of HIV-1 genetic diversity in Russia during the last two decades: increase of the recombinants prevalence
A. Antonova
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Phylogenetic analyses applied to the study of transmission variants in a HIV-1 positive couple
A. BergnaÂ
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Unexpected rising in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies.
M. Alkhatib
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
HIV Incidence and Sexual Behaviors among Men Who Have Sex with Men Using Geosocial Networking Smartphone Application in Beijing, China: an Open Cohort Study
M. Zhang
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
High PrEP awareness and intention to use but suboptimal uptake among Hornet users in the Asia-Pacific
H. Schmidt
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Is risk compensation real? The effect of perceived level of HIV transmission risk on risk behavior in an open-label pilot PrEP-based intervention in men who have sex with men in Malaysia
K. Rankin
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Situational Analysis of HIV pre-exposure prophylaxis among gay men, other men who have sex with men and transgender women in Myanmar
A. Oo
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
PrEP or condoms, or both? Insights on risk compensation through a discrete choice experiment on PrEP preferences among gay, bisexual, and other men who have sex with men
R. Tan
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Lower prevalence of TB infection before initiating antiretroviral therapy after treatment at any CD4 in the Thai HIV National AIDS Program
W. Jantarabenjakul
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
HIV treatment outcomes among people who inject drugs in the Asia-Pacific: an observational cohort study
W. Han
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Prevalence Trend of Transmitted Drug Resistance in a Prospective Cohort of Thai People with Acute HIV Infection
C. Muccini
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Prevalence and the impact of low-level viremia among people living with HIV taking protease inhibitors or dolutegravir-based antiretroviral therapy
G. Chen
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
High retention but low virological suppression rates among HIV-infected infants with early antiretroviral treatment in the Thai national program
T. Puthanakit
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Comparison of digital and facility-based HIV/Syphilis self-testing secondary distribution modes among men who have sex with men in China
Y. Sha
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Modified self-obtained pooled sampling to screen for Chlamydia trachomatis and Neisseria gonorrhoeae infection in men who have sex with men
N. Ando
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020